Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

NCT02624349 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02624349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02624349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
Lead sponsor
The Hospital for Sick Children
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2017
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication of transplanted liver, human papillomavirus-related carcinoma, late complication from kidney transplant